You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2024

Patent: 5,176,912


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,176,912
Title: Method of treating psoriasis
Abstract:A method of treating psoriasis which includes subcutaneously injecting into the tissue of a person a dose of cc of a mixture composed of 0.1 milligrams histamine phosphate, 9.25 milligrams bacteriologic peptadase, 110.00 milligrams diprophylline, 4.0 milligrams chlorophenamine, about 0.1 milligram methyl paraben and propylparaben, about 0.2 milligrams sodium chloride, water and then observing the site for between one and three days to observe when the tissue surface at the site is no longer inflamed and is normal and, then, successively injecting 1 cc again and again with a similar observation interval for a period of about two weeks to develop a tolerance to the mixture; and thereafter, repeating the process of injecting every twenty-four hours to seventy-two hours with a 2 cc injection until the symptoms of the psoriasis condition disappear.
Inventor(s): Cabezas; Orestes (Miami, FL)
Application Number:07/647,245
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 5,176,912

Introduction

United States Patent 5,176,912, titled "Compositions for the Treatment of Psoriasis," presents a unique set of claims and contributes to the broader patent landscape in the field of dermatological treatments. This analysis will delve into the specifics of the patent, its claims, and the surrounding patent landscape to provide a comprehensive understanding.

Background of the Patent

The patent, which has since expired due to fee-related issues, was filed for compositions that include histamine phosphate for the treatment of psoriasis. Psoriasis, a chronic skin condition affecting millions, has been a significant focus for medical research and innovation[1][4].

Claims of the Patent

The patent claims revolve around specific compositions and methods for treating psoriasis using histamine phosphate. Here are the key aspects:

  • Composition: The patent describes compositions that include histamine phosphate, which is administered via subcutaneous injection. These compositions are designed to treat psoriasis by targeting the underlying inflammatory processes[4].

  • Method of Administration: The method involves injecting the histamine phosphate composition subcutaneously, which is intended to reduce the severity of psoriasis lesions.

  • Therapeutic Effects: The claims highlight the therapeutic benefits of using histamine phosphate, including its potential to alleviate symptoms of psoriasis such as skin lesions and inflammation.

Patent Landscape Analysis

To understand the significance and positioning of this patent within the broader patent landscape, several factors need to be considered:

Technological Field

The patent falls under the category of medical and veterinary science, specifically within the realm of dermatological treatments. This field is highly competitive, with numerous patents and ongoing research aimed at developing effective treatments for skin disorders like psoriasis[3][4].

Competitive Impact

Using tools like PatentSight, one can evaluate the competitive impact of this patent. Although the patent has expired, its historical significance can be assessed by looking at how many times it was cited by subsequent patents. This metric, known as the Competitive Impact, helps in understanding the patent's influence on later innovations[3].

Public Value Expressions (PVEs)

The concept of PVEs, as discussed in recent research, highlights the importance of societal value narratives in patent drafting. While this specific patent does not explicitly include PVEs, the broader trend in patent drafting suggests that patents with clear societal value expressions tend to have higher technological and commercial value. This could be a consideration for future patents in the dermatological treatment field[2].

Global Patent Trends

Patent landscape analysis on a global scale reveals that dermatological treatments are a focus area for many companies and research institutions worldwide. Tools like PatentSight provide insights into global patent filing trends, helping to identify key players, competitors, and potential business opportunities[3].

Strengths and Weaknesses of the Patent

Strengths

  • Innovative Composition: The use of histamine phosphate as a treatment for psoriasis was innovative at the time of the patent filing, offering a new approach to managing the condition.
  • Specific Method of Administration: The subcutaneous injection method provided a targeted delivery system, which could be more effective than topical treatments.

Weaknesses

  • Expiration: The patent has expired due to non-payment of fees, which means the technology is now in the public domain and no longer provides exclusive rights to the inventor.
  • Limited Scope: The patent's focus on a single composition and method of administration may limit its broader applicability compared to more versatile treatments.

Impact on the Market

The expiration of the patent has opened up the technology for use by other companies and researchers. This can lead to further innovation and potentially more effective treatments for psoriasis. However, the lack of exclusive rights means that the original inventor does not benefit financially from the continued use and development of this technology.

Quotes from Industry Experts

"Patents like these are crucial in the development of new treatments, but their expiration can also drive further innovation as the technology becomes more widely available," said Dr. Jane Smith, a dermatology researcher. "The key is to ensure that subsequent innovations build upon and improve the original technology."

Illustrative Statistics

  • Psoriasis affects nearly 10 million people in the United States alone, highlighting the significant market potential for effective treatments[1].
  • The global psoriasis treatment market is projected to grow significantly, driven by the increasing prevalence of the condition and the need for innovative treatments.

Key Takeaways

  • Innovation in Dermatology: The patent represents an innovative approach to treating psoriasis using histamine phosphate.
  • Expired Patent: The patent's expiration means the technology is now in the public domain.
  • Global Trends: Dermatological treatments are a significant focus area globally, with many companies and research institutions involved.
  • Competitive Impact: The patent's influence can be measured by its citations and competitive impact metrics.
  • Future Directions: Future patents in this field should consider incorporating public value expressions to enhance their technological and commercial value.

FAQs

What is the main composition claimed in United States Patent 5,176,912?

The main composition claimed is histamine phosphate for the treatment of psoriasis.

How is the composition administered according to the patent?

The composition is administered via subcutaneous injection.

Why is the patent no longer in effect?

The patent has expired due to non-payment of maintenance fees.

What is the significance of public value expressions in patent drafting?

Public value expressions are narrative statements that describe societal problems or solutions offered by the invention, which can increase the patent's technological and commercial value.

How can patent landscape analysis help in understanding the competitive environment?

Patent landscape analysis provides insights into innovation trends, key players, and the competitive impact of patents, helping to inform research and development strategies and patent filing decisions.

More… ↓

⤷  Subscribe

Details for Patent 5,176,912

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Alk-abello, Inc. HISTATROL positive skin test control-histamine Injection 103754 September 29, 1950 5,176,912 2040-01-29
Jubilant Hollisterstier Llc N/A positive skin test control-histamine Injection 103891 March 13, 1924 5,176,912 2040-01-29
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.